Linden invests in Aspirion

Overview

Deal Type Mergers & Acquisitions
Client & Transactional Partners Linden Capital Partners
Aspirion
Aquiline Capital Partners, LLC
Our Role Buy-Side Advisor

Summary

Linden Capital Partners, a Chicago-based private equity firm focused exclusively on the healthcare industry, announced that it has acquired Aspirion, a leader in technology-enabled healthcare revenue cycle management. Aspirion is a leading healthcare RCM provider across complex claims and revenue integrity, offering a broad array of technology-driven solutions for the most specialized revenue cycle challenges faced by hospital systems and healthcare providers. The company's team of healthcare, legal, and technical professionals, in conjunction with its proprietary AI-enabled software, assists hospitals and physicians in improving claims processing times and overall collections.

Linden has made a majority investment in Aspirion, a leader in tech-enabled healthcare RCM. Linden plans to support Aspirion and position the company for continued growth through strategic investments in technology and M&A. Aspirion's management team and Aquiline Capital Partners will remain investors in the Company.

Cain Brothers

B I Deal Disclosure

KeyBanc Capital Markets is a trade name under which the corporate and investment banking products and services of KeyCorp and its subsidiaries, KeyBanc Capital Markets Inc., member FINRA/SIPC (“KBCMI”), and KeyBank National Association (“KeyBank N.A.”), are marketed. Securities products and services are offered by KeyBanc Capital Markets Inc. and by its licensed securities representatives. Banking products and services are offered by KeyBank N.A.

Recent Deals

July 2025

a portfolio company of 

and

$1.815 Billion

Senior Secured Credit Facilities

$900 Million

8.50% First Lien Secured Notes due 2032

Joint Lead Arranger
Joint Bookrunner

radiology-partners
June 2025

 

El Camino Commons

$74.8 Million

Construction Loan & LIHTC Equity

el-camino-commons
June 2025

Hill Estates

Hill Estates

$67.5 Million

Bridge to Perm Loan, Acquisition

hill-estates
June 2025

thermogenics

a portfolio company of

audax

acquired by

morgan stanley

Sell-Side Advisor

thermogenics

Connect With Us

Find an Expert